Arturo Araya, MBA
Arturo Araya joined BrainStorm in February 2017. He has nearly two decades of international pharmaceutical experience in the commercialization, marketing, and general management of cellular therapies. At Novartis’s Cell and Gene Therapies Unit, he was Vice President and Head of Global Commercial, where he led a cross-functional team to commercialize a portfolio of cellular and gene therapies. As Global Brand Leader for CTL019, a chimeric antigen receptor (CAR)-T cell therapy, he was responsible for developing early launch plans, including worldwide and multiple indication forecasts and resource modeling. He led the Oncology Unit for Novartis in seven countries. Prior to Novartis, Mr. Araya was with Bristol-Myers Squibb as Associate Director of Marketing Intelligence, Business Development & Licensing.
Mr. Araya earned an MBA from the University of Michigan. He also holds an MA in Political Science and a BS in Civil Engineering from the University of Connecticut.